DONADON, Matteo Davide
 Distribuzione geografica
Continente #
AS - Asia 4.889
EU - Europa 4.240
NA - Nord America 3.698
SA - Sud America 719
AF - Africa 655
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.214
Nazione #
US - Stati Uniti d'America 3.480
RU - Federazione Russa 2.857
SG - Singapore 1.627
HK - Hong Kong 1.039
CN - Cina 825
VN - Vietnam 530
BR - Brasile 528
BJ - Benin 516
FR - Francia 346
KR - Corea 327
IT - Italia 276
DE - Germania 254
GB - Regno Unito 136
IN - India 135
MX - Messico 113
CA - Canada 91
AR - Argentina 78
UA - Ucraina 78
BD - Bangladesh 69
IQ - Iraq 51
JP - Giappone 47
ZA - Sudafrica 47
PL - Polonia 45
ES - Italia 44
FI - Finlandia 42
ID - Indonesia 41
NL - Olanda 37
TR - Turchia 32
EC - Ecuador 29
SE - Svezia 27
PK - Pakistan 25
VE - Venezuela 22
CO - Colombia 20
DZ - Algeria 18
IE - Irlanda 15
SA - Arabia Saudita 15
LT - Lituania 14
UZ - Uzbekistan 13
AT - Austria 12
CL - Cile 12
MA - Marocco 11
BE - Belgio 10
EG - Egitto 10
JO - Giordania 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
NP - Nepal 9
PE - Perù 9
PH - Filippine 9
TH - Thailandia 9
KE - Kenya 8
PY - Paraguay 8
TN - Tunisia 8
UY - Uruguay 8
AU - Australia 7
CH - Svizzera 7
SN - Senegal 7
BH - Bahrain 6
ET - Etiopia 6
IL - Israele 6
KG - Kirghizistan 6
SY - Repubblica araba siriana 6
AL - Albania 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
GA - Gabon 4
NG - Nigeria 4
RO - Romania 4
AO - Angola 3
AZ - Azerbaigian 3
HU - Ungheria 3
JM - Giamaica 3
LB - Libano 3
RS - Serbia 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
GR - Grecia 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
MD - Moldavia 2
MR - Mauritania 2
MT - Malta 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
TG - Togo 2
TO - Tonga 2
WS - Samoa 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
Totale 14.193
Città #
Hong Kong 1.031
San Jose 894
Singapore 738
Ashburn 580
Cotonou 516
Moscow 369
Seoul 310
Lauterbourg 300
Los Angeles 226
Beijing 168
Ho Chi Minh City 165
Buffalo 154
Hanoi 123
New York 103
Falkenstein 100
Dallas 87
Redondo Beach 79
Seattle 77
Orem 67
São Paulo 65
Santa Clara 60
Assago 56
Mexico City 54
Tokyo 43
Warsaw 41
Tianjin 39
Chicago 38
Montreal 36
Chennai 35
Guangzhou 35
Frankfurt am Main 34
Helsinki 33
Atlanta 32
Brooklyn 31
Milan 31
Novara 31
Council Bluffs 30
Da Nang 29
Amsterdam 27
London 27
Manchester 27
Denver 26
Johannesburg 25
Munich 24
Poplar 24
Stockholm 24
Phoenix 23
Haiphong 22
Mumbai 21
Hangzhou 20
Boston 19
Shanghai 19
Sona 19
New Delhi 17
Baghdad 15
Rio de Janeiro 15
Rome 15
San Francisco 15
St Louis 15
Toronto 15
Dublin 14
Curitiba 12
Shenzhen 12
Tashkent 12
Brasília 11
Houston 11
Amman 10
Ankara 10
Can Tho 10
Dalian 10
Dhaka 10
Querétaro 10
Basra 9
Buenos Aires 9
Elk Grove Village 9
Fortaleza 9
Jakarta 9
Nuremberg 9
Turku 9
Vancouver 9
Bologna 8
Brussels 8
Charlotte 8
Erbil 8
Lahore 8
Vercelli 8
Belo Horizonte 7
Biên Hòa 7
Calgary 7
Cape Town 7
Düsseldorf 7
Istanbul 7
Porto Alegre 7
Quito 7
Caracas 6
City of London 6
Dakar 6
Delhi 6
Goiânia 6
Hải Dương 6
Totale 7.638
Nome #
Safety of intermittent pringle maneuver cumulative time exceeding 120 minutes in liver resection : a further step in favor of the "radical but conservative" policy 144
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment 101
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC – B and – C: an Italian multicentric analysis 91
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparison 79
IRON: A retrospective international multicenter study on robotic versus laparoscopic versus open approach in gallbladder cancer 79
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma 77
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial 76
6,126 hepatectomies in 2022: current trend of outcome in Italy 74
AN ANTI-MICA/B MONOCLONAL ANTIBODY SUPPORTS ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY TO INTRAHEPATIC CHOLANGIOCARCINOMA CELLS 71
Methylprednisolone or N-Acetylcysteine in Hepatic Resections: Results from a Pilot, Double-Blind, Randomized Clinical Trial 71
Drop-out between the two liver resections of two-stage hepatectomy for multiple bilobar colorectal metastases: Patient selection or loss of chance? 70
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target 69
Hepatocellular carcinoma surgical and oncological trends in a national multicentric population: the HERCOLES experience 68
Association of indirect measurement of cell function by bioimpedance analysis with complications in oncologic hepatic surgery 64
Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent 64
Assessment of the American College of Surgeons surgical risk calculator of outcomes after hepatectomy for liver tumors: Results from a cohort of 950 patients 64
Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients 63
Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort 63
A new systematic small for size resection for liver tumors invading the middle hepatic vein at its caval confluence: mini-mesohepatectomy 62
[Surgical treatment of liver metastases from colorectal carcinoma] 62
Filamin a expression predicts early recurrence of hepatocellular carcinoma 62
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 62
A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers : is it adherent to the EASL/AASLD recommendations? : an observational study of the HCC east-west study group 61
Oncological outcome of R1 vascular margin for mass-forming cholangiocarcinoma. A single center observational cohort analysis 61
Monopolar floating ball versus bipolar forceps for hepatic resection: A prospective randomized clinical trial 61
ONE STAGE HEPATECTOMY FOR MULTIPLE BILOBAR COLORECTAL LIVER METASTASES 61
ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma 61
Is R1 Vascular Hepatectomy for Hepatocellular Carcinoma Oncologically Adequate? Analysis of 327 Consecutive Patients 61
"Radical but conservative" is the main goal for ultrasonography-guided liver resection: Prospective validation of this approach 60
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 60
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular Carcinoma 60
Anatomical Resection of Segment 8 by Means of Ultrasound-Guided Vessel Compression 59
Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid-enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure 59
Anatomical right posterior sectionectomy: a further expansion of the ultrasound-guided compression technique 59
Morphology of tumour-associated macrophages dictates the prognosis of patients with colorectal liver metastases 59
Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study 59
Radical but Conservative Liver Resection for Large Centrally Located Hepatocellular Carcinoma: The Mini Upper-Transversal Hepatectomy 58
PET/CT Standardized Uptake Value of 11C-choline as a Predictor of Long-Term Survival in Patients Operated for Hepatocellular Carcinoma: A Preliminary Report 58
Individualized risk estimation for postoperative morbidity after hepatectomy: the Humanitas score 58
Measurement of Total Liver Volume Using the Energy Expenditure: A New Formula 57
"Radical but conservative" is the main goal for ultrasonography-guided liver resection : prospective validation of this approach 57
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 57
A systematic review of the predictive factors for the recurrence of acute pancreatitis 56
Versatile Mass Spectrometry-Based Intraoperative Diagnosis of Liver Tumor in a Multiethnic Cohort 56
Reflections and perspectives on adjuvant treatment in the setting of resected hepatocellular carcinoma 56
Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence 56
Impact of Oocyte Extract Supplement on Quality of Life after Hepatectomy for Liver Tumours: A Prospective, Multicentre, Double-Blind Randomized Clinical Trial 56
PERITUMORAL CD3+INFLAMMATION AND NEUTROPHIL TO LYMPHOCYTE RATIO PREDICT OVERALL SURVIVAL IN PATIENTS AFFECTED BY COLORECTAL LIVER METASTASES TREATED WITH SURGERY 56
Liver resection for primary neuroendocrine tumours: report of three cases and review of the literature 56
Predictive role of peritumoral CD3+infiltration and neutrophil to lymphocyte ratio on overall survial in pateints affected by colorectal liver metastases treated with chemotherapy and surgery 55
Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients 55
Upfront Surgery versus Neoadjuvant Perioperative Chemotherapy for Resectable Colorectal Liver Metastases: A Machine-Learning Decision Tree to Identify the Best Potential Candidates under a Parenchyma-Sparing Policy 55
A critical analysis of surgical outcomes indicators in hepato‐pancreato‐biliary surgery: From crude mortality to composite outcomes 55
Intratumoral CD3+and Nkp46+Cells Protect Against Tumor Progression in Resected Colorectal Liver Metastases Treated With Neoadjuvant Chemotherapy 55
A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers : is it adherent to the EASL/AASLD recommendations? : an observational study of the HCC east-west study group 55
Conservative Hepatectomy for Tumors Involving the Middle Hepatic Vein and Segment 1: The Liver Tunnel 54
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 54
A Phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of non-oncogenic RTKs 54
Intrahepatic CD69 + v 1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression 53
Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study 53
Preoperative Identification of Communicating Vessels Among Hepatic Veins in Patients Undergoing Liver Surgery for Tumors at the Caval Confluence 53
Multiple Minor Hepatectomies vs Major or Extended Hepatectomies for Colorectal Liver Metastases: A Propensity Score-Matched Dual-Institution Analysis 53
Hepatic resection (HR) versus laparoscopic radiofrequency (RF) in the treatment of hepatocellular carcinoma (HCC) of liver cirrhosis: A prospective comparative study 53
A Snapshot of Elective Oncological Surgery in Italy During COVID-19 Emergency: Pearls, Pitfalls, and Perspectives 52
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 52
Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery 51
Impact of RAS mutations on the immune infiltrate of colorectal liver metastases: A preliminary study 51
Safety and Effectiveness of Systematic Long-Term Drains Maintenance After Hepatic Resection 51
Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways 51
Anatomical resection of segment 8 by means of ultrasound-guided vessel compression 51
Parenchyma-Sparing Liver Surgery for Large Segment 1 Tumors: Ultrasound-Guided Lateral and Superior Approaches as Safe Alternatives to Major Hepatectomy 51
EWALT: East Meets West in a Multidisciplinary Setting to Improve the Management of Liver Tumors 51
COVID-19: emerging challenges for oncological surgery 50
How Much Is Enough? A Surgical Perspective on Imaging Modalities to Estimate Function and Volume of the Future Liver Remnant before Hepatic Resection 50
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 50
Is Enhanced One-Stage Hepatectomy a Safe and Feasible Alternative to the Two-Stage Hepatectomy in the Setting of Multiple Bilobar Colorectal Liver Metastases? A Comparative Analysis between Two Pioneering Centers 50
Textbook Outcomes and Minimally Invasive Techniques in Resectable Gallbladder Cancer: A Global Cohort Study 49
A new systematic small for size resection for liver tumors invading the middle hepatic vein at its caval confluence: mini-mesohepatectomy 49
Role of surgical resection for hepatocellular carcinoma in the Barcelona-Clinic-Liver-Cancer classification: A prospective study 49
Safety and Effectiveness of Systematic Long-Term Drains Maintenance After Hepatic Resection 49
Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma 49
Radiofrequency of hepatocellular carcinoma in patients with liver cirrhosis : a critical appraisal of the laparoscopic approach 48
Surgery and Hepatocellular Carcinoma 48
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 48
Anatomical resection of segment 8 by means of ultrasound-guided vessel compression 48
Systemic Chemotherapy and Two-Stage Hepatectomy for Extensive Bilateral Colorectal Liver Metastases: Perioperative Safety and Survival 47
Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy? 47
Contrast-Enhanced Intraoperative Ultrasonography during Hepatectomies for Primary and Metastatic Tumors: Results in a Prospective Cohort of Patients 47
Hepatectomy for Metabolic Associated Fatty Liver Disease (MAFLD) related HCC: Propensity case-matched analysis with viral- and alcohol-related HCC 47
Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance? 47
Oncologic superiority of anatomic resection of hepatocellular carcinoma by ultrasound-guided compression of the portal tributaries compared with nonanatomic resection: An analysis of patients matched for tumor characteristics and liver function 47
Surgery for cholangiocarcinoma 47
Management of intrahepatic cholangiocarcinoma: a review for clinicians 46
A Snapshot of the Effective Indications and Results of Surgery for Hepatocellular Carcinoma in Tertiary Referral Centers: Is It Adherent to the EASL/AASLD Recommendations? An Observational Study of the HCC East-West Study Group Reply 46
Hepato-renal hydatid cyst: a case report of diagnosis and management of an uncommon disease presentation 46
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? 46
Anatomical Segmental and Subsegmental Resection of the Liver for Hepatocellular Carcinoma A New Approach by Means of Ultrasound-Guided Vessel Compression 46
Effects of volume on outcome in hepatobiliary surgery: a review with guidelines proposal 46
Safe Hepatectomy Selection Criteria for Hepatocellular Carcinoma Patients: A Validation of 336 Consecutive Hepatectomies. The BILCHE Score 46
Anatomical right posterior sectionectomy: a further expansion of the ultrasound-guided compression technique 45
Totale 5.765
Categoria #
all - tutte 56.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 0 0 0 1 2
2022/202318 1 1 2 0 1 0 1 0 9 0 3 0
2023/202419 1 0 0 1 4 1 4 0 1 1 2 4
2024/20254.039 1 5 8 0 13 1.066 687 232 861 377 131 658
2025/202610.497 513 349 780 1.182 1.526 897 1.953 1.877 789 631 0 0
Totale 14.576